These included the top MYCNARB1PRO downregulated TSTD1 and CDKN2C genes, which also showed a significantly lowered expression in MYCN-amplified compared with the MYCN-silent neuroblastomas (Fig 4E). This evidence concerns the gene MYCN and neuroblastoma.